Invention Application
- Patent Title: ANTIBODY-PEPTIDE FUSION PROTEINS FOR TREATING AMYLOID DISORDERS
-
Application No.: US18907295Application Date: 2024-10-04
-
Publication No.: US20250101090A1Publication Date: 2025-03-27
- Inventor: Jonathan S. WALL , James S. FOSTER , Spencer GUTHRIE , Jaume PONS , Michael L. KLEIN
- Applicant: University of Tennessee Research Foundation , Attralus, Inc.
- Applicant Address: US TN Knoxville; US CA Burlingame
- Assignee: University of Tennessee Research Foundation,Attralus, Inc.
- Current Assignee: University of Tennessee Research Foundation,Attralus, Inc.
- Current Assignee Address: US TN Knoxville; US CA Burlingame
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K51/10 ; C07K14/00
Abstract:
Provided herein are antibody-peptide fusion proteins comprising an amyloid-reactive peptide linked to an antibody. Also provided herein are methods of treating amyloid-based diseases by administering an antibody-peptide fusion protein.
Information query
